Clinical Trials · NCT07734870
Tirzepatide for Treatment of CCCA
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Johns Hopkins University
- Enrollment
- 20
- Start date
- Sep 2026
- Locations
- 2 sites, United States
- Primary endpoint
- Change in Central Centrifugal Cicatricial Alopecia Clinical Activity Tool Score